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INCREASING PNEUMOCOCCAL POLYSACCHARIDE VACCINATION RATES IN
ADULTS AGE 65 YEARS AND OLDER IN A PRIMARY CARE CLINIC

An Abstract of the Scholarly Project by
Ashley Sandbothe

The purpose of this study was to increase PPSV23 vaccination rates in adults over
the age of 65 years in a Midwestern primary care clinic.
For this project, staff was educated regarding interventions including patient
awareness, provider recommendation, staff and provider education, vaccine access, use of
the immunization information systems (IIS) and appropriate use of electronic health
record (EHR) reminders that have been shown to increase vaccination rates.
Prior to the intervention, data was retrieved, and it was found that between April
1st-May 31st 2020, there were 162 patients over the age of 65 that presented to the clinic.
Of those 112 were already vaccinated or received the PPSV23 vaccination, indicating
that the clinic had a 69% vaccination rate at baseline. After the project intervention and
during the 8-week study period of April 1st-May 31st 2021 there were 190 patients over
the age of 65 seen and 151 of those patients were either already vaccinated or received
the PPSV23 vaccination. This increased the rate of vaccination to 79%. Those who
continued to refuse the vaccination were given a questionnaire to asking for potential
reasons.
Vaccination rates increased in the studied primary care clinic from 69% to
79%.This shows these intervention techniques are successful at increasing vaccination
rates in a primary care clinic.
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Chapter I

Introduction

Pneumococcal vaccination is an important preventive health measure that can
help reduce the rate of pneumococcal infections. According to the Centers for Disease
Control and Prevention (CDC) (2019a), the Healthy People 2020 goal “is to achieve at
least 90% coverage for pneumococcal polysaccharide vaccine among persons 65 years of
age and older.” However, this same data suggests that only 64% of persons 65 years of
age or older had ever received pneumococcal vaccination. Additionally, more than 65%
of people who have been hospitalized with pneumococcal disease within the last 3–5
years were not offered the vaccine (CDC, 2019b). Healthy People 2030 goals for
immunizations, such as the pneumococcal vaccination are currently still under
developmental status, this means that it is a “high-priority public health issue that has
evidence-based interventions to address it, but doesn’t yet have reliable baseline data
(Office of Disease Prevention and Health Promotion, n.d.).
Opportunities are missed in our health system every day, both inpatient and
outpatient. Therefore, more effective programs are needed to ensure there is an increase
in vaccination rates. These missed opportunities show the importance of this study.
The CDC recommends all adults receive routine administration of pneumococcal
polysaccharide vaccine (PPSV23) at age 65 years or older (CDC, 2019c). This is a one-
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time vaccination after age 65. If the patient received one dose prior to age 65, then the
dose after age 65 should be given at least 5 years from the prior dose (Musher, 2020).
This is the vaccine of focus for this project.
Description of the Problem
Over 11,500 cases and more than 1,900 deaths occurred in adults over the age of
65 from invasive pneumococcal disease in the United States in 2016 (CDC, 2020a). More
than half of the cases that occur each year in adults have an indication for pneumococcal
polysaccharide vaccine (CDC,2019b). These statements prove statistical significance and
need for improvement of PPSV23 rate.
The impacts of the PPSV23 are well documented. Getting vaccinated can protect
the individual receiving the vaccination. If the majority of a community gets vaccinated,
that community can develop herd immunity which decreases the likelihood that the
community will get the disease. This would cause a decreased chance of an outbreak
because it is more difficult for the disease to spread. The PPSV23 vaccination is known
to be 60%–70% effective in preventing disease caused by serotypes included in the
vaccine (CDC, 2019b). Therefore, getting the vaccination decreases the likelihood of
contracting illness caused by pneumococcal disease.
Pneumococcal disease causes many different illnesses that are preventable by
vaccination. These include diseases such as pneumonia, bacteremia, meningitis, and otitis
media. The solution to decreasing the prevalence of these diseases would be increasing
the number of adults who receive the pneumococcal vaccination.
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Significance to Nursing and Patients
Improving vaccination rates is significant in improving the health of the older
population. A nurse's role is to improve the health outcomes of all populations; therefore,
vaccine compliance is significant to nursing. Education, surveillance, and understanding
could all help improve vaccination rates.
Medical staff and provider education regarding vaccines is a factor that limits
vaccination rate improvement. Adult vaccination remains a low priority for both
physicians and patients (Doherty et al., 2018). As adults, employers rarely require proof
of vaccination. Also, many patients are unaware of the recommended immunizations, and
health care providers do not have time to assess vaccination at every appointment.
According to Ventola (2016) approximately “65% of people were aware of the
pneumococcal vaccine, 56% had not gotten it because their doctor had not recommended
it.”
Surveillance is necessary in order to set goals, establish priorities and be able to
monitor the effectiveness of the program for future adjustments (Doherty et al., 2018).
Immunization records are often incomplete for adults. Lack of accurate vaccination
records may also cause missed opportunities to educate and vaccinate patients (Ventola,
2016).
Safety, value, and efficacy of vaccination should be understood by both those
vaccinating and those receiving the vaccination (Ventola, 2016). This can also be closely
related to education because at the time of recommending the vaccination the provider
should be able to educate the patient regarding these attributes. An increase in education
of vaccination improvement is a responsibility of providers if rates are going to change.
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Purpose
The purpose of this project is to increase pneumococcal vaccination rates in the
adult population age 65 years and older in a Midwestern primary care clinic. The project
will be implemented using provider/staff education to increase assessment of patient
vaccination status every appointment/every visit, utilizing appropriate electronic health
record (EHR) reminders and providing education regarding the PPSV23 vaccination.
After this implementation if a patient still continues to refuse vaccination, there will be a
survey questioning the patient as to why the vaccination was refused. The goal is to
determine if there will be an increase in PPSV23 vaccination rates compared with current
office strategies among adults age 65 and older in a primary care clinic.
Theoretical Framework
This project was grounded using a model called the P3 model that was developed
with preventative health in mind. In an article by Bednarczyk et al. (2018) the authors
discuss the development of this model in comparison with other theoretical frameworks.
The model is able to address the practice-level, provider-level, and patient-level
components that are often involved in preventive care such as vaccine rate improvement.
The P3 model was made by gathering key components of other conceptual models,
“including the Health Belief Model, Theory of Planned Behavior/Theory of Reasoned
Action, Social Cognitive Theory, Social Ecological Model, and the Systems Model of
Clinical Preventive Care” (Bednarczyk et al, 2018, p.131). Since this model was formed
with preventative care in mind it assumes that prevention is the goal. Bednarczyk,et al
(2018) states that the “P3 Model allows for inclusion of factors at levels that may not be
addressed fully through standard health promotion and behavioral models” (p.136). An
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example of this would be if a provider does not follow the standard best practice
guidelines.
This framework is a great blueprint for the project because it encompasses most
of the issues that may be a cause of low vaccination rates. At the practice level, there are
ways for improvement for example, such as correct utilization of standing orders or if the
clinic has an available supply of vaccinations. The provider level is able to determine if
there is vaccine hesitancy due to lack of education or if a provider just is not correctly
utilizing the electronic health record (EHR) prompts. Finally, it looks at the patient level
and is able to determine reasons why the patient may be the reason for not vaccinating,
such as fear of needles, unknown vaccine schedule or fear of costs.
Figure 1 Graphical Representation of the P3 Model
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Note. This representation of the P3 model shows identification of impacting factors and
the levels they act within the model (adapted from Bednarczyk et al 2018).
Needs Assessment Tool
The strength, weakness, opportunities and threat analysis tool is also known by
the acronym SWOT. Using a SWOT analysis to examine a project enables the
examination of the project’s positives and negatives. This analysis tool acts as an
additional framework to help assist and find ways to eliminate or improve on the project
weaknesses and to discover opportunities that are available for improvement. If these
aspects of a project are known, a person is “more likely be able to plan and act
effectively” (Center for Community Health and Development, n.d.).
This particular tool was chosen in addition to the P3 model because in order to
improve vaccination rates an assessment of needs must be completed to understand the
strengths and weakness of the current practice. This tool helps examine ways that may
help improve vaccination rates or find barriers that may cause issues for vaccination rate
improvement. This can be done at the clinic level, the provider level or the patient level
as previously discussed with the P3 model. There are many factors that affect why a
patient chooses to get a particular vaccination or not and in order to improve vaccination
rates those factors need to be considered.
Analysis Results
The SWOT analysis (Table 1) indicates many items under each identified
category. This list is not inclusive and during project development there is anticipation
that other items will arise in all categories. Internal issues, both strengths and weaknesses
are being defined here as tasks that are controlled within the organization such as clinic
6

factors (hours, location, etc.), provider factors (willingness, education, etc.) and staff
factors. External factors are both opportunities and threats, which are out of the
organization control, such as patients, insurance, and national guidelines.
For internal strengths, the biggest and most important is probably related to the
amount of evidence supporting the vaccination effectiveness and decrease in disease
following vaccination. The clinic where the project will be completed has good access to
care. There are nurse visit slots that enable patients who have been seen within a year to
schedule appointments for vaccination. There are multiple providers at the clinic who are
available from 7am-5pm. These providers all have several same-day appointment slots.
These are appointments slots that are unable to be booked until the same day. The EHR at
this facility is Epic, which does allow for patient and provider reminder of vaccinations
that are due. The clinic always stocks the PPSV23 vaccination and has not had any issues
keeping it in stock. The staff and the providers at this clinic are aware of a needed change
and improvement and are willing to implement new protocols. Several people within the
facility have access to the State of Missouri immunization information system website to
obtain historical vaccines to update immunization records if the patient is unsure of the
date the vaccination was received or where they received it at.
For internal weakness there were also many identified issues that could be
improved at a clinic level. Although the EHR has the capability for reminders it is not
being utilized. The utilization of the nurse schedule for vaccines is not being utilized as
there are currently no standing orders available for vaccination administration. The final
issue identified was time restraints of providers and staff members required to further
assess each patient visit for immunization status and provide education regarding the
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vaccination if needed.
External opportunities were found. The most important is that increasing the rate
of vaccination will lead to a decrease in the amount of pneumococcal illness. Decreased
hospital visits were another important factor for community opportunity. Ultimately,
improved vaccination will save the healthcare system financially.
External threats to PPSV23 rate improvement include anything that risks a
vaccination not being administered. This includes those who refuse to receive the
vaccination. These reasons can vary, such as religion, fear of needles, fear of cost, and
fear of adverse reaction. Other reasons may include the patient being unaware of the
vaccination schedule, if they are due for the vaccine, or the vaccine is effectiveness.
Many patients and providers fear cost associated with vaccinations, so another external
factor is insurance coverage for the vaccine. Lastly, the pneumococcal vaccination
administration guidelines were updated in November 2019 which increased confusion of
the new dosing schedule (CDC, 2019c).
Considering both positive and negative factors that affect immunization rate
improvement, there seemed to be enough evidence to support the need for modification
and improvement of the current process. Results of these factors are displayed in the
Table 1. Positive factors are displayed (+) along with negative factors (-).
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Table 1
SWOT Analysis
Strengths

Weakness

Opportunities

Threats

+ Evidence
supporting
vaccination

-EHR reminders
not being correctly
utilized

Leading to:
+ Increased
vaccination rates

-Those who are
opposed to vaccines

+Access to care
+Technology and
reminders
+Vaccine
availability
+Staff and provider
willingness
+Access to state
vaccine
immunization
information
systems

-No standing
orders
-Provider and staff
time restraints
-Vaccine status not
being assessed

-Insurance coverage
of vaccinations
+ Decreased
pneumococcal
disease/diagnoses
+Decreased hospital
visits
+Healthcare savings

-Timing with the
covid19
vaccination roll
outs

-New
pneumococcal
vaccination
guidelines
-Patient perception
to vaccine
effectiveness, need
and/or risks
associated
-Patient fear (cost
or fear of needles)
-Covid19
vaccination

Project Questions
•

What are the barriers to receiving the pneumococcal vaccination among adults
aged 65 years and older?

•

Will staff/provider education regarding appropriate EHR reminders, assessing
vaccination status every patient/every time and the use of standing orders improve
vaccination rates?
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•

Will asking the patient, providing patient education and provider recommendation
improve vaccination rates?

•

Will the clinic see an increase in vaccination among adults after project
implementation?
Definition of Key Terms
The following terms will be seen by the reader throughout this paper. For better

understanding, the definitions are provided here.
Healthy People 2020 – “Healthy People is a set of goals and objectives with 10-year
targets designed to guide national health promotion and disease prevention efforts to
improve the health of all people in the United States” (Department of Health and Senior
Services, 2010)
Herd immunity- Also called community immunity, this is is “A situation in which a
sufficient proportion of a population is immune to an infectious disease (through
vaccination and/or prior illness) to make its spread from person to person unlikely”(CDC,
2020b).
Immunization- “The process of being made immune or resistant to an infectious disease,
typically by the administration of a vaccine. It implies that you have had an immune
response” (CDC, 2020b)
Meningitis- “Inflammation of the brain and spinal cord that can result in permanent brain
damage and death” (CDC, 2020b)
Otitis Media- “A viral or bacterial infection that leads to inflammation of the middle ear”
(CDC, 2020b).
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Pneumonia- “Inflammation of the lungs characterized by fever, chills, muscle stiffness,
chest pain, cough, shortness of breath, rapid heart rate and difficulty breathing” (CDC,
2020b).
Polysaccharide vaccines- “Vaccines that are composed of long chains of sugar
molecules that resemble the surface of certain types of bacteria. Polysaccharide vaccines
are available for pneumococcal disease” (CDC, 2020b).
Provider- Medical care professional with specialized training that individual that is able
to assess, diagnose, and treats individuals with medical conditions; physicians,
physician’s assistant, or nurse practitioner
Vaccination- “The physical act of administering any vaccine or toxoid” (CDC,2020b).
Logic Model
A logic model (Figure 2) was created to visualize the project. The logic model
identifies the inputs and outputs utilized to create an intervention. It also identified the
short-term, medium-term, and long-term goals of the scholarly project. Lastly, it denotes
assumptions of the author, as well as external factors that could influence the project.
This model depicts the identification of pneumococcal vaccination inputs that will be
used to support the project, resources/activities to overcome barriers, and expected
outcomes of provider/staff education regarding vaccine administration. The model also
lists outcomes. The outcomes section of this model has been divided into time frames,
including short, mid, and long term with the ultimate goal of disease elimination.
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Figure 2
Logic model for increasing pneumococcal vaccination rates

Summary
The recommended use of the PPSV23 vaccination can prevent the risk of
pneumococcal-related diseases and decrease the risk of mortality. Primary care clinics
have the capability of providing this immunization for all adults age 65 and older. Health
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care providers must strive to find effective strategies to increase recommended
vaccination rates and prevent illness. The goal of this project will provide insight on how
an improved process can increase PPSV23 vaccination rate and bridge the gap towards
the Healthy People 2020 goal.
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Chapter II

Literature Review

In the United States, pneumococcal illness causes many different types of disease.
Pneumococcal disease is more than just pneumonia and can include acute bacterial
diseases such as pneumonia, meningitis, bacteremia, sinusitis, and otitis media. These
diseases are predominately an issue for those age 65 and older or those with chronic
medical conditions.
Impact
In order to explain the importance of the vaccine, it is important to look at several
of those illnesses and their impact to determine how the vaccine can decrease illness
rates. However, the elderly population or age 65 and older is considered a vulnerable
population. This age group has an increased risk of pneumococcal disease and will be the
population of focus for this scholarly project.
Pneumococcal Pneumonia
According to the CDC (2019b), approximately 400,000 hospitalizations from
pneumococcal pneumonia are estimated to occur annually in the United States. This type
of pneumonia has a case-fatality rate of 5-7% and has proven to be much higher in the
elderly population. So, the use of the PPSV23 vaccination has the potential to decrease
the potential of fatality in this population group.
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Bacteremia
About 25-30% of patients with pneumococcal pneumonia also experience
pneumococcal bacteremia, where a person develops bacteria in the bloodstream. There
are more than 12,000 cases of this occurring yearly in the United States. The fatality rate
is up to 60% in the elderly population (CDC, 2019b). This again, can be decreased with
vaccination.
Meningitis
Pneumococcal bacteria is the cause for over 50% of all cases of meningitis in the
United States. The case-fatality rate of pneumococcal meningitis is about 22% among
adults (CDC, 2019b). The incidence of meningitis has decreased since the introduction of
the pneumococcal vaccine and could be further decreased with vaccination rate
improvement.
Otitis Media
Other causes of pneumococcal illness are also present. Another illness occurs in
the form of otitis media (ear infection). Pneumococci is detected in 28%–55% of ear
infections (CDC, 2019b). Decreasing the number of ear infections could save a lot of
unnecessary visits to primary care and urgent cares for antibiotics.
Decreasing each of the above listed illnesses could save healthcare dollars.
Additionally, increasing vaccination rates can decrease illness at both the state and
national levels. This can be achieved by the improvement of an adult vaccination
program for PPSV23 vaccination.
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Significance
As stated in the introductory chapter, low rates of pneumococcal vaccinations are
an issue in the United States. Per the Centers for Disease Control (CDC), opportunities to
vaccinate are missed both inpatient and during outpatient visits to healthcare offices
(2019b). Effective programs for vaccine delivery are needed. Since the development of
the pneumococcal vaccines, pneumococcal disease has shown a decline. According to
trends pneumococcal disease caused by the serotypes covered by PPSV23 declined from
51 cases per 100,000 people in 1998 to 13 cases per 100,000 people in 2015 in adults 65
or older (CDC, 2017). This improvement proves the efficacy of vaccination and further
proves the need for increased vaccination efforts in hopes of disease eradication. The
CDC also discusses immunization strategies for improved vaccination rates. However, a
more thorough literature review needs to be done to gain current evidence-based research
regarding increasing vaccination rates in the adult population.
Literature Review
The attempt to determine a reason behind the low pneumococcal polysaccharide
vaccination rates in adults above age 65 requires a review of the literature. This review is
used to examine similarities, differences, and patterns of behaviors among providers and
patients and obtain the most recent information on vaccinations, knowledge and
administration. This literature review was conducted using the online databases CINAHL
and PubMed. The CDC website was an online database that was also utilized for
vaccination knowledge because the CDC website is a primary resource for best practice
guidelines regarding vaccination. The focus of the literature review was broad in terms of
all vaccination types for adults to find why all vaccination uptake is low and was not
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specific to the pneumococcal vaccines because there was a lack of available literature
found specific to pneumococcal vaccinations.
The initial keywords searched, and search phrases, were: “adult pneumococcal
polysaccharide vaccination rate improvement”, “vaccination rate improvement”, “adult
pneumococcal vaccination barriers”, “improving vaccine uptake” and “interventions to
improve adult vaccination rates.” Results were further narrowed down to include only
articles in English, those available in full text and articles included were all free and
available without payment. Upon completion of database search, 13 articles were chosen
within the criteria based on a review of the article abstract.
The review of the literature resulted in many common themes for low vaccination
rates in the adult populations. The common barriers will be discussed along with ways to
decrease barriers and increase vaccination uptake. According to multiple studies, vaccine
coverage for recommended vaccines is low among adults (Barker et al., 2016; Bock et al.,
2016; Bridges et al., 2015; Clark et al., 2018; Ho et al., 2017). Each study identified
barriers to vaccination. Many of the studies sought to identify a more effective approach
to improve vaccination rates. The barriers identified were lack of provider
recommendation, lack of awareness that the vaccination exists, lack of knowledge
regarding schedule, safety or efficacy, vaccination access, cost, and provider concerns.
Provider Recommendation
Studies have shown that recommendations from a patient’s health care provider
have a significant impact on immunization rates, yet many patients report they do not
receive these recommendations from their clinicians (Bock et al., 2016; Bridges et al.,
2016; Clark et al., 2018; Sandler et al., 2016; Zimmerman et al., 2017). According to
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Sandler et al. (2016) who studied vaccination rates in patients with Rheumatoid arthritis,
only 3 out of 4 patients said that their providers discussing their risk of infection and only
2 out of 3 said their providers discussed vaccinations. Another study indicated that 88%
of people said that would be more likely to receive a vaccination if it included a strong
recommendation from their physician (Bridges et al., 2016).
The CDC (2019a) also supports this. They state that a provider recommendation
“remains the number one reason parents decide to vaccinate” and even patients who are
initially reluctant are likely to get a vaccination when provider has a positive attitude
toward the vaccination (CDC, 2019a). This same source also discusses that providers
offering vaccinations should use a presumptive approach and assume that the patients
being seen will choose to vaccinate (CDC, 2019a).
These statistics show the importance of provider recommendation for patients.
However, there were also many barriers to providers recommending vaccination that
were also identified in the literature.
Provider/Staff Education
Provider and staff education seemed to be the most common theme identified.
Most of the studies identified provider and staff barriers to vaccination rate improvement.
Common themes included lack of familiarity regarding the vaccine or the schedule,
difficulty using EHR reminders and/or order sets, uncertainty about the efficacy and/or
safety of the vaccine, and uncertainty about insurance coverage and prior vaccination
history.
“Interventions to improve immunization rates have focused on modifying health
care providers’ behavior to encourage them to promote vaccines for adults” (Clark et al.,

18

2018, p.292). In order to achieve this, many of the studies studied the effectiveness of
providing provider and staff education to increase familiarity regarding the vaccination
and the schedule (Barker et al., 2016; Chan et al., 2015; Bridges et al., 2016; Sebold et
al., 2018). This is further supported by the fact that many providers get confused about
the recommended vaccination schedules (Bridges et al., 2016; Clark et al., 2015). There
were ways identified to assist these barriers.
One of the identified issues for health care providers was time constraints
(MacDougall et al., 2015). Sander et al. (2016) also noted that physicians have
insufficient amounts of time to discuss and address preventative care needs that are
necessary. One of the ways to combat time restraints is through the use of standing
orders. Bridges et al. (2016) found that system interventions such as the use of standing
orders and use of EHR reminders for vaccines that were due were strategies that
enhanced health care providers’ success with increasing vaccination rates. Several other
studies also discussed the utilization of standing orders to remove some burden from the
physicians (Bock et al., 2016; Sandler et al., 2016).
In addition to standing orders and reminders, Clark et al. (2015) offered additional
recommendations for the use of clinical decision support tools that further aid in
screening and reminders to ensure administration of vaccines on encounters with patients.
Another tool discussed was the use of best practice advisory (BPA) tools (McAdam-Marx
et al., 2016). A BPA is a pop-up reminder in the EHR that serves as an intervention that
is triggered based on patient demographics to let you know when something is overdue
such as vaccines (McAdam-Marx et al., 2016). The last tool identified to aid providers in
increasing vaccination rates is the use of audit and feedback. The use of this tool was
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discussed in Clark et al. (2018) and Clark et al. (2015). Audit and feedback measured the
performance of the provider compared with a set standard. The results are then shared,
and those results are meant to motivate to meet the defined targeted goals. The
anticipation is that the provider will modify practice if they know their performance does
not meet the standard (Clark et al., 2018).
Education of providers is important. Providers should be prepared and able to
answer questions using common terms that patients are able to understand. Vaccine risks
and benefits are important for providers to be aware of to aid in responding to
misinformation and concerns that patients may have. Providers can also train staff to
discuss these basic vaccine questions to help save time during visits and ensure patients
are hearing consistent messages about vaccines (CDC, 2019a). Consistency often helps
relay a positive message and helps the patient have a better understanding which
increases the likelihood they will receive the vaccination.
Each of these different tools can help assist the provider to identify patients who
are due for the needed vaccination. This can then be used to appropriately assess
vaccination status. Then, ultimately recommend vaccination when needed to raise
awareness.

Lack of Awareness

According to Bock et al. (2016), 84% of the people surveyed are unaware that a
pneumococcal vaccination even exists for adults. In this study this lack of awareness was
identified as the main barrier to not receiving a vaccination. This was also discussed as a
leading factor impacting vaccination status in the study by Bridges et al. (2016). Also, in
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a study by Ho et al. (2016), many of the participants were familiar with influenza
vaccinations but many had never heard of pneumococcal vaccination.
Lack of education regarding safety, efficacy and vaccine schedule are other
reasons patients do not receive vaccinations. Zimmerman et al. (2017) discusses these
patient-related barriers to include not knowing that a vaccine was recommended, not
believing that the clinician recommended the vaccine, and fear of vaccine side effects.
According to Bridges et al. (2016), one of the main reasons for not getting vaccinated
was “the belief that the vaccine was not needed because they were healthy” (p.117). This
was also an identified theme in a study by MacDougall et al. (2016) where participants
thought that all relevant vaccines were administered in childhood. Eighty-three percent of
people in this same study said that they would be more likely to receive a vaccination if
they had more knowledge about the vaccine effectiveness (Bridges et al., 2016). Ho et al.
(2016) discussed that the main barriers identified by research were “poor knowledge of
vaccinations and fear of side effects.” This lack of education leads to decreased
vaccination rates.

Access to Vaccines

Access to care and vaccinations was another reason that many patients state they
are unable to be adequately vaccinated. Bridges et al. (2016) discusses that pharmacies,
workplaces and other retail settings are becoming important places for adults to receive
vaccinations. They offer access and convenience for patients that many healthcare
settings do not. Other studies also discussed the importance of expanding access to sites
where patients can be vaccinated (Clark et al., 2015; MacDougall et al., 2015). Bridges et
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al. (2016), states that 30% of adults getting vaccinated in a retail/pharmacy setting do so
during times when healthcare offices are typically closed, such as on weekends or in the
evenings. Another gap that was identified was that there is often difficulty accessing a
consistent primary care provider, so this forces patients to seek care at a variety of
locations where they receive vaccines at multiple places without proper communication
between facilities (MacDougall et al., 2015).
The CDC also identified access barriers. Clinic hours were again discussed for
those patients who are working long hours and are unable to make it into a clinic, and
long wait times at clinics waiting to see a provider and transportation issues were all
identified (CDC, 2019a). Overcoming these barriers such as extending clinic hours,
staggering schedules, and holding vaccination clinics were all ways listed to overcome
these obstacles (CDC, 2019a). These obstacles regarding access increase the need for
better communication amongst healthcare organizations in order to improve vaccine
coverage.
Immunization Information Systems (IIS)
Electronic health records can help increase vaccination rates. It was discussed
under the provider recommendation section in terms of reminders and order sets/standing
orders. Another way to use technology to assist in increased vaccination rates is through
the use of immunization information systems (IIS). IIS are computer-based databases that
record vaccination doses that are given by participating healthcare professionals/ entities
who live in a certain area (Groom et al., 2015). A study by Groom et al. (2015) looked at
the IIS function in order to create ways to increase vaccination rates, determine vaccine
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status, and provide missed vaccine opportunities. Other studies also briefly mention that
IISs could also contribute to improving adult vaccination rates (Bridges et al., 2016).
According to the CDC (2019a), the use of IIS is important at both the level of clinical
care and at the population level. IIS can provide a one stop shop for immunization
histories on a patient that a clinician is able to use to see if a vaccine is due at the time of
service (CDC, 2019). The use of IIS can also provide aggregate information for use in
disease surveillance and for helping direct public health officials with goals to increase
vaccine use and decrease the rates of vaccine preventable disease (CDC, 2019a)
IISs can be retrieved in clinical settings and offices to see which vaccines the
patient is due for. This system allows for a more up to date/complete vaccination record.
IIS also eliminate the need of having to rely on patient memory or recall.
Cost
The last theme identified throughout the literature seems to be one that was least
discussed: cost. This may be due to providers and patients having little to no control over
cost. It basically comes down to organizations and insurance coverage. Regardless, cost
was identified as a common theme for vaccination hesitancy. Bock et al. (2016) found
that almost 5% of people surveyed said that they were not vaccinated due to cost. Bridges
et al. (2015) further explains that there are many factors to consider in terms of cost,
including “how adult vaccinations are paid for by private and public insurers, limited
funding for vaccination of uninsured adults, costs of and requirements for stocking
vaccines, concerns among providers about adequate reimbursement for vaccination.”
Vaccination rates are shown to be lower in adults who do not have health insurance
(Bridges et al., 2015). Reducing out-of-pocket expenses is one way that was identified to
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increase vaccination rates (Clark et al., 2015). Some people even believe that
vaccinations for the elderly should be provided free of charge (Ho et al., 2017).
Not only do patients have cost concerns, but so do organizations. MacDougall et
al. (2015) discussed the cost of purchasing and stocking vaccinations at the clinic level.
This coupled with the unknown reimbursement rates of most insurance companies seems
to provide fear that decreases providers willingness to offer the vaccine. Decreasing costs
of vaccinations or having vaccination programs that offer lower costs could increase
vaccination rates by allowing patients affordability and by increasing provider
willingness to recommend.
Practice Change Recommendations
Increasing vaccination rates will require several different interventions. It was
identified that providers and staff need to assess the vaccination status of patients at every
clinical encounter. Second, using available reminder tools in the EHR (both sick and well
visits can increase vaccination rates). Third, providers need to strongly recommend
vaccines that are needed, and vaccinations need to be offered at the same visit those
vaccinations are recommended. If vaccines are not available, the patient should be
offered a referral for the vaccination. Finally, the vaccinations need to be documented
(which includes the use of IIS).
Summary
Many common themes were identified for barriers to receiving vaccinations.
These barriers were provider recommendation to receive the vaccination, staff and
provider education regarding the vaccination in terms of schedule, efficacy and side
effects, lack of awareness about the availability of the vaccine, access to the vaccine, the
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use of the IIS and appropriate use of EHR reminders and cost. Each of these individual
factors work together to ultimately increase vaccination rates.
Provider recommendation was identified as a primary reason a patient chooses to
vaccinate or not. Providers and staff should assess vaccination status of every patient at
every appointment. They should also be educated to provide an evidence-based
recommendation for the patient’s timing in receiving the vaccination. In addition, they
should be available to answer questions the patient may have regarding the vaccine. This
will help ensure the patient has awareness that a vaccine exists. The use of the EHR
should be utilized for reminders and apply IIS to obtain complete vaccination histories on
patients. Lastly, providers and healthcare organizations need to ensure clinic hours are
adapted or that schedules are staggered to help patients obtain access to care.
These barriers are important to understand in order to create ways to overcome
them. The use of the practice change recommendations will improve vaccination rate
improvement. These interventions will help provide a basis for project development.
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Chapter III

Methodology
The project design and target population were selected after analysis of the CDC’s
and ACIP’s recommendations of the pneumococcal polysaccharide (PPSV23)
vaccination for adults, as well as a review of literature of vaccinating this age group. The
target population for this study was chosen because the ages 65 and older is believed to
have the greatest risk for contracting and having issues from the diseases for which the
vaccination protects against. Pneumococcal disease is proven to be associated with
pneumonia, meningitis, otitis media and bacteremia as discussed in the previous chapters.
The focus of this project was to provide education to increase the vaccination rate of
PPSV23 in adults age 65 years and older in a primary care clinic in the Midwest.
Immunizations were offered on-site by the clinic where the study was performed. This
chapter will discuss the methodology implemented to perform this study.
Project Design
The project followed a quasi-experimental design evaluating the rate of
pneumococcal vaccination before and after the educational intervention with the clinic
staff. The education intervention was provided to each person employed at the clinic who
comes in contact with patients on a regular basis. The front desk staff was educated
regarding the importance of providing handouts to all patients who were overdue for any
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and all health maintenance topics which included the pneumococcal vaccination. The
pneumococcal vaccination, if over-due was highlighted to draw specific attention for the
purpose of the project. This allowed the patients to review the paperwork after check-in,
make corrections and review the information with the nurse upon rooming. The nurse,
while rooming assessed pneumococcal vaccination status for every patient at every
encounter and if applicable obtained documentation of past immunizations from another
provider, pharmacy, or the state immunization information system (IIS). If the patient
required a pneumococcal vaccination and agreed, the nurse used standing orders to
administer the vaccination. When administering the pneumococcal vaccination, the nurse
also provided the patient with a vaccination information sheet (VIS). Finally, the provider
saw the patient and if vaccination has not already been completed, asked the patient about
the pneumococcal vaccination by using the EHR reminder/care gaps. The provider then
educated the patient regarding the pneumococcal vaccination guidelines and
effectiveness. At checkout, if the pneumococcal vaccination had still not been ordered,
the patient was asked to complete anonymous questionnaire about reasons for refusing
the vaccination. This questionnaire included a variety of reasons why the vaccination was
not received or refused, such as fear of needles, fear of cost, religious preference, was not
asked, do not know enough information, etc.
Data collected was both quantitative and qualitative in nature. The quantitative
data was retrieved using the clinics EHR, Epic. Quantitative data consisted of baseline
pneumococcal vaccination status of all adults seen in the clinic in the twelve months prior
to project implementation and was obtained through a review of the clinic’s EHR and
was used to compare patient vaccination status for the PPSV23 vaccine before and after
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project implementation. Data was obtained with the assistance of the clinic manager and
consisted of only numbers of vaccinations and was free of patient identifiers. Additional
data retrieved was related to demographics data such as race and gender. This
information was also free of patient identifiers. Qualitative data about patient’s refusal
reasons was collected from all patients who refused vaccination during the project time
frame.
Before and after comparison of patient vaccination status was used to determine if
staff education lead to improved pneumococcal immunization rates. Then, if staff
education was ineffective, a questionnaire was given to determine what additional
reasons patients gave for vaccination refusal. This information was gathered to guide
future projects.
Action/Procedure
After gaining approval from SSM Healthcare and Pittsburg State University,
education was provided to the staff at the SSM Family Practice Clinic in Jefferson City,
MO. Education was presented during the next staff meeting following approval. The
date staff education was performed was on March 16, 2021. Collected data was divided
into two categories (i) those who are immunized following the appointment and (ii) those
who were not.
Target Population
The target population for this study was made up of patients at or above 65 years
of age who were seen at the clinic during the data collection period.
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Inclusion/Exclusion Criteria
Participants included all patients over the age of 65 years of age who were seen at
the SSM Edgewood Clinic in Jefferson City, MO during the study period. Information
about race, ethnicity and gender was collected to assess if a difference exists in the
demographics of those who agree to the vaccine and those who do not. Patients who
spoke other languages were included as well. This clinic utilized a computer-based
translation system so all patients were able to understand the information being
presented.
Patients who were not seen during the study period were excluded from the study.
Additionally, patients younger than 65 years of age were also excluded. Patients were not
excluded based on race, ethnicity of language as stated above.
Setting
The project took place at the SSM Edgewood Family Practice Clinic in Jefferson
City, MO. This clinic is a family practice clinic that offers primary care services which
include, preventative screenings, mental health care, chronic disease management, illness
visits and well man and well woman visits. The SSM Health organization accepts all
insurance plan and sees patients regardless of ability to pay.
Protection of Human Subjects
An Institutional Review Board (IRB) application was submitted to the Pittsburg
State University Committee for the Protection of Human Research Subjects (CPHRS) for
review and approval. Upon review, the study qualified for exempt status. All interactions
with subjects remained confidential, no personal information was obtained from patients
participating in the educational intervention, the vaccination data collected did not
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include any personal identifiers. Moreover, the study did not include vulnerable subjects
such as children or prisoners.
Data collection took place after the proper institutional review process was
completed and final approval was obtained from Pittsburg State University and the Irene
Ransom Bradley School of Nursing. All quantitative data was collected using the Epic
EHR and only numbers of vaccinated or unvaccinated patients were obtained and was
free of any patient identifier. Qualitative data was collected in the form of an
administered questionnaire. No deception of subjects took place, nor techniques used that
caused discomfort or harassment. Confidentiality was maintained with the questionnaires;
no identifying patient information was collected, and completed questionnaires were
placed securely in a ballot box after visit which was not be opened until after study
completion for data collection. Consent was implied if the patient chose to complete the
survey.
Ethical Considerations
An ethical dilemma regarding vaccination rate improvement involves the balance
of personal autonomy and choice versus protection of both that individual and the entire
community at risk. A vaccine provides a dual benefit: a direct benefit to the person
receiving it, and an indirect benefit to other members of the community by offering herd
immunity. Patients will often look up to healthcare providers when making medical
decisions, including vaccinations. Most healthcare providers, favor vaccination and seek
ways to overcome these patients’ resistance. In turn, providers face the challenge of
balancing the ethical principles of non-maleficence (do no harm) and beneficence (do
good) when educating patients regarding vaccine choices.
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These principles can often be in conflict when addressing vaccine risks. In doing
good, the provider would have the responsibility to promote vaccines for the benefit of
the patient and community, despite opposition. However, looking at the principle of nonmaleficence requires the provider to inform patients of the risk of the vaccinations and
therefore might lead patients to refuse the vaccination the provider is promoting.
Ideally, decisions about vaccination should be reached through mutual
participation in a shared decision-making process which would promote patient
autonomy and avoid coercion.
Instruments
A cross-sectional questionnaire survey on resistance or refusal to vaccination was
administered to patients who continued to refuse the PPSV23 vaccination after
intervention. The survey inquired about lack of education, lack of provider
recommendation, religious beliefs, and other reasons behind refusing the PPSV23
vaccine. Implied consent was assumed with completion and return of the survey. This
tool was implemented to enhance the validity of the study’s results and future attempts at
educating on PPSV23 vaccination to directly target reservations to vaccinate.
Procedure
After IRB approval, the educational offering to staff took place on March 16,
2021 in collaboration with SSM Health. This offering consisted of a discussion at staff
meeting regarding the importance of the PPSV23 vaccination and how vaccination rates
can be improved. At the end of the presentation, participants were able to ask questions to
the researcher if desired.
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After the educational offering clinic staff immediately started implementing
discussed behaviors which included providing patients with handout for overdue health
maintenance at every visit, assessing pneumococcal vaccination status at every
appointment and obtaining historical vaccination or administering vaccinations if due.
Patients who continued to refuse were given a post survey asking for reasons for refusal.
The project will occur during an eight-week time period, through April 1st to May 31st,
2021. During this time, staff continued implementation strategies to hopefully increase
vaccination rates and offering surveys to those who refuse. After project completion, data
was run through Epic which is the EHR system utilized by SSM Health. This data was
compared to previously collected data from one year prior to implementation to assess
improvement. Data was obtained by the help of the clinic manager. Surveys were
collected from the ballot box, and responses were analyzed for reasons of vaccination
refusal. Demographic data to include age, gender, and ethnicity were retrieved from the
EHR to evaluate any difference in the demographics of those who agree to the vaccine
and those who don’t.
Budget
No cost was incurred for the survey or project. The creation and distribution of
the surveys utilized paper provided by the SSM health clinic. Patients were not offered
reimbursement for participation.
Strengths/Limitations
A limitation identified is the guideline update to the pneumococcal administration
guidelines in November of 2019. This guideline update could have caused some
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confusion to staff and providers. Some providers and staff do not stay current on
guidelines.
Covid19 was also a limiting factor for this study. Initially it was planned that
there would be another clinic included, however, due to the pandemic, and social
distancing, educational opportunities were difficult. Additionally, the Covid19
vaccination was a priority due to the global pandemic, so this vaccination took
precedence over the pneumococcal vaccination. Current guideline recommended that no
vaccination should be administered within two weeks pre and post Covid19 vaccination
series.
Strengths identified are that vaccinations were available at the clinic and could be
given the same day that they were offered. Additionally, Covid19 also could be viewed as
a strength. This was due to many patients may have had an altered opinion regarding
vaccinations during the pandemic.
Evaluation plan
The goal of the data collected was to determine whether or not new procedures
would increase PPSV23 vaccination rates in adults age 65 years and older in a primary
care clinic in Jefferson City, MO when comparing rates from the previous year. In
comparing vaccination rates from the same time frame from the previous year a rise in
rates would indicate the need for improved clinical process for vaccination education and
administration. The survey results were an important addition to the data gathered
because they may indicate how future interventions could be done to help increase
vaccination rates. Depending on what the analysis shows, education interventions similar
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to the one implemented in this study could be replicated to further improve rates of this
vaccination or others.
Project Sustainability
If intervention proved effective in increasing PPSV23 vaccination rates among
older adults, bi-annual attempts toward staff education using the strategies implemented
in this study would be warranted to use in this clinic and other primary care clinics
throughout the state of Missouri to improve overall vaccination coverage. Plans to
execute a universal educational intervention to be used throughout the state would require
a multidisciplinary approach to ensure sustainability. Collaboration between many clinics
would be essential for the replication and implementation of the interventions utilized in
this study.
Summary
Increasing vaccination rates should be focus of all healthcare providers.
Healthcare providers play a key role to significantly increase vaccination rates through
the use of screening and education. The goal of this project was to increase PPSV23
vaccination rates. This chapter discussed in detail the population studied, the procedure
for study development and data collection. By comparing pneumococcal vaccination
rates to those in the prior year, we can assess if vaccination rates increased after
intervention. This knowledge would encourage staff to always assess and ask patients
about vaccines, which will increase vaccination awareness, and thus increase vaccination
rates.
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Chapter IV

Evaluation of Results

The purpose of this study was to increase PPSV23 vaccination rates in adults over
the age of 65 years in a midwestern primary care clinic. The project also attempted to
find out why patients continue to refuse the PPSV23 vaccination after the intervention
strategies were utilized to help aid in future projects. Staff was educated to notify the
patient that they are overdue for the PPSV23 vaccination by assessing vaccination status
at every appointment for every patient, obtaining historical vaccinations data from other
providers, pharmacies or the state IIS, and ultimately administering the vaccination after
providing education to the patient. Data collection started after staff education was
provided and rates were compared from one year prior to the educational intervention.
This chapter will discuss the population that was studied. It will provide an
analysis of the data collected as it relates to the purpose of the project. Finally, it will
discuss the results of the project in detail.
Sample
Once approval was gained from Pittsburg State University IRB and SSM Health,
employees were offered an educational intervention that consisted of a PowerPoint
presentation regarding intervention techniques that would be used within the clinic to
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hopefully increase PPSV23 vaccination rates. This staff education was performed on
March 16, 2021. Data collection began on April 1, 2021 and ran through May 31, 2021.
Inclusion criteria were all patients who were scheduled to be seen in the clinic
during the data collection period who were age 65 or older. Information about race,
ethnicity and gender was also collected to assess if a difference exists in the
demographics of those who agree to the vaccine and those who do not. Patients who
speak other languages were also included, as the clinic utilizes a computer-based
translation system so patients were able to understand the information and give consent.
Patients not seen during the study period were excluded from the study.
Additionally, those patients younger than 65 years of age were also excluded.
Data was collected through a report ran through the clinics EHR record, EPIC.
This allowed for historical data to be retrieved from one year prior to the study before the
staff education to compare to current data after the education.
Project Variables
The independent variable for this study was the education that was provided to
staff members of the SSM Family Medicine Clinic in Jefferson City, MO. The education
emphasized the importance of the PPSV23 vaccination, along with efficacy, side effects,
vaccination schedule and what data has been shown to help increase vaccination rates.
The dependent variable for this study was the clinics vaccination rates prior to and
after the educational intervention for the staff. The goal was to see if the dependent
variables were affected by the provided education. The perceived barriers to vaccinate
were included in an anonymous survey that was given to the patient after the patient visit
was complete. The effect on the dependent variable was shown in comparison to the
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previous year vaccination rates to the rates after the education was done and new
techniques were initiated.
Analysis of Project Questions
Data was collected to address the aforementioned needs and answer the following
project questions:
•

What are the barriers to receiving the pneumococcal vaccination among adults
aged 65 years and older?

•

Will staff/provider education regarding appropriate EHR reminders, assessing
vaccination status every patient/every time and the use of standing orders improve
vaccination rates?

•

Will asking the patient, providing patient education and provider recommendation
improve vaccination rates?

•

Will the clinic see an increase in vaccination among adults after project
implementation?

Research Question 1
Question one was “what are the barriers to receiving the pneumococcal
vaccination among adults aged 65 years and older?” This question was addressed through
a review of the literature and it was found that the lack of provider recommendation was
the foremost barrier to vaccination. Another barrier included lack of provider or staff
education in terms of vaccination schedules, difficulty using EHR reminders and/or order
sets, uncertainty about the efficacy and/or safety of the vaccine, and uncertainty about
insurance coverage and prior vaccination history. Lack of patient awareness, vaccination
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access, and cost were other identified barriers to receiving vaccinations that were
addressed.
This was also further assessed in a post survey for vaccination refusal to see if any
additional barriers existed. Out of the 39 patients who refused vaccination between the
study dates, 22 surveys were returned. The survey results showed the majority, 8 out of
22 people refused based on the Covid19 vaccination. Those wanting to receive or who
had already received the Covid19 vaccination had to wait two weeks pre-series and two
weeks post-series before receiving another vaccination. Five people listed “I don’t want
to” as a reason. Four people expressed safety concerns primarily related to allergies or
other medication sensitivities. Other reasons were also listed and are displayed in Table 4
below.
Research Question 2
Question number two was “will staff/provider education regarding appropriate
EHR reminders, assessing vaccination status every patient/every time and the use of
standing orders improve vaccination rates?” This was addressed after the project was
performed. Baseline clinic vaccination rates before implementation of staff and provider
education was at 69%. Data was historically retrieved from the EHR from one-year prior
to the education. After the educational training that was done on March 15, 2021, a
second period of data was ran from April 1-May 30, 2021 which showed the clinic
vaccination rate after staff and provider education was increased to 79%.
Research Question 3
Question number three was, “will asking the patient, providing patient education
and provider recommendation improve vaccination rates?” which can be answered
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collectively with question two. Pre-intervention before asking the patient, proving patient
education and provider recommendation the baseline clinic vaccination rate was at 69%.
After these intervention techniques, the clinic vaccination rate was at 79%.
Research Question 4
The final research question was “will the clinic see an increase in vaccination
among adults after project implementation?” This was answered by comparing baseline
data prior to the project intervention. Baseline data was at 69%. This data was compared
the data after staff education and new implementation of assessing vaccination status at
every patient appointment, so they are aware of the vaccination, providing patient
education and then recommending the patient receive the vaccination. The after
invervention PPSV23 vaccination rate ended at 79%.
Additional Analysis
Baseline data was retrieved from the clinic EHR, EPIC. The total of number of
patients seen over the age of 65 in the SSM Family Medicine clinic during April 1- May
31, 2020 totaled 161 patients. 112 of these patients had historical vaccinations recorded
or received vaccinations during this time period which showed the clinic had a 69%
baseline vaccination rate during this two-month time period. Table 2 below shows the
total number of patients, those were vaccinated versus unvaccinated and shows
comparisons based on gender, race and ethnicity.

39

Table 2
Baseline PPSV23 Vaccination Rates April 1-May 30, 2020
VACCINATED

UNVACCINATED

TOTAL=162

All patients
over age 65

112

50

GENDER

Men

47

27

Women

65

23

White

109

50

Black

1

0

Pacific Islander

1

0

Hispanic

1

0

Not Hispanic
Latino

110

50

Other Ethnicity

2

0

RACE

ETHNICITY

Staff education was provided using the PowerPoint that is displayed in Appendix
B. This was performed on March 15, 2021. Project implementation spanned from April
1-May 31, 2021. Project implementation consisted of giving patients an overdue health
maintenance handout when the patient checked in for their appointment by the front
reception staff. This handout stated all screening tests/vaccinations that were overdue
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(colonoscopy, mammogram, CT lung cancer screening, etc.). The PPSV23 vaccination, if
due, was highlighted using a yellow highlighter to draw attention to this specific
vaccination. The patient held onto this sheet of paper while in the waiting room until their
roomed appointment time. The nurse, while rooming, assessed the status of the PPSV23
vaccination status at every patient appointment. If the vaccination was overdue, the nurse
asked the patient if they previously had received this vaccine. If yes, they attempted to
gain documentation of this historically given vaccination either from the state IIS or from
a previous provider. If the patient had not previously received the vaccine, they were then
asked if they would like to have the vaccination on the date they were in the office. If the
patient required more information the staff provided education regarding the vaccination
schedule, efficacy, side effects, and purpose of the vaccination. The nurse would then
administer the vaccination with standing orders. Additionally, when the provider went to
see the patient after the rooming process, they would also look in the EHR to see if the
pneumococcal vaccination had been documented and if not use the EHR reminders to
recommend the vaccination to the patient, find out if they had any additional questions
and then ultimately ask if they were interested in receiving the vaccine. If the patient
continued to refuse the vaccine, then at checkout, patients were anonymously asked to
submit a survey asking about reasons why and submit this survey into a locked ballot
box. This ballot box sat at check-out desk during the day, was locked into a cabinet
drawer at night and only the researcher had access to the key to ensure it could not be
accessed during the project period. Following the project completion date on May 31,
2021, data was collected via the EHR in the same manner as the historical data was
retrieved.
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The total of number of patients seen over the age of 65 in the SSM Family
Medicine clinic during April 1- May 31, 2021 totaled 190 patients. 151 of these patients
had historical vaccinations recorded or received vaccinations during this time period
which showed the clinic had a 79% vaccination rate during this two-month time period.
Table 3 shows the total number of patients, those who were vaccinated versus
unvaccinated, and shows comparisons based on gender, race and ethnicity.
Table 3
PPSV23 Vaccination Rates April 1-May 30, 2021 After Implementation

TOTAL=190
GENDER

RACE

ETHNICITY

VACCINATED

UNVACCINATED

151

39

Men

49

9

Women

102

30

White

146

39

Black

2

0

Pacific Islander

0

0

Hispanic

0

0

Asian

3

0

Not Hispanic
Latino

151

39

All patients
over age 65
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Other Ethnicity

0

0

Additionally, a compilation of responses from the surveys from those who
continued to refuse vaccination were analyzed for reasons of vaccination refusal. Refusal
reasons are compiled in Table 4.
Table 4
Pneumococcal Vaccination Survey Results
Quantity

Reason from Survey

Patient comments (if any)

5

Other, please describe

“I just don’t want to.”

1

Fear of needles

8

Wanting to receive or had
already received the
Covid19 vaccination
Safety concerns

4

“have a lot of allergies,
fear of allergy”
“does not do vaccines
based on sensitivities to
other meds.”
“too sensitive to
everything.”
“do not want anything
extra like that in my body.”

2
1
1

Prefer not to disclose my
reasoning
Personal belief
Multiple boxes checkedreligious reasons, personal
belief, and safety concerns
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“do not believe in
vaccines.”

Summary
This purpose of the present study was to increase PPSV23 vaccination rates in
adults over the age of 65 years in a midwestern primary care clinic. This was done after
provider and staff education. Results of the data analysis and comparison revealed
findings significant to the purpose of the study. The study outcomes indicate that
education on staff may have a positive effect on increasing vaccination rates. The clinic
vaccination rates increased from 69% to 79%, which showed that these interventions
were successful in increasing vaccination rates.
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Chapter V

Discussion

The intention of this project was to see if staff education and selected intervention
would increase pneumococcal polysaccharide vaccination rates in adults over the age of
65 in a midwestern primary care clinic. The number of patients who were vaccinated with
the PPSV23 vaccination from April 1-May 31, 2020, were compared to those who were
vaccinated in the same time frame in 2021 after staff education was performed at the
clinic being studied. The data collected indicates that staff education in terms of making
patients aware, assessing vaccination status at every appointment, following provider
recommendations, and the using of standing orders and appropriate EHR reminder
utilization does increase PPSV23 vaccination rates in adults over the age of 65 years.
Relationship of Outcomes to Research
One of the supporting opening statements that was made to introduce this project
was that the Healthy People 2020 goal “is to achieve at least 90% coverage for
pneumococcal polysaccharide vaccine among persons 65 years of age and older” (CDC,
2019a). However, since the original project was started Healthy People 2030 goals have
been formed. This goal changed slightly and is now is more generalized and states
“Reduce the rate of hospital admissions for pneumonia among older adults.” Older adults
are those age 65 years and older. This guideline is using a baseline of 713.9 hospital
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admissions for pneumonia per 100,000 adults aged 65 years and over in 2016 and has a
target of 642.5 admissions per 100,000 adults of the same age. The evidence-based
resources related to this objective refers back to the pneumococcal vaccination guidelines
(Office of Disease Prevention and Health Promotion, n.d.).
There are two other Healthy People 2030 objectives that are currently under
developmental status relating back to this study in terms of vaccinations but are not
specific to PPSV23 vaccination. These objectives are to “increase the proportion of
immunization information systems that track adult immunizations across the lifespan”
and “Increase the proportion of adults age 19 years or older who receive recommended
age-appropriate vaccines.” However, these two objectives are still under development
which means that they are being viewed as a high-priority public health issue that has
evidence-based interventions to address it, but there is no current reliable baseline data
(Office of Disease Prevention and Health Promotion, n.d.).
The data gathered in this project does not correlate with the 2030 goals, but data
did fall short of the Health People 2020 goal at only raising pneumococcal vaccination
rates from 69-79%. However, a 10% improvement in vaccination rates did show
significant improvement after only a two-month study period.
Observations
Noteworthy observations made were that vaccination rates were affected by the
global Covid19 pandemic. This was included on the post-vaccination refusal survey.
Patients who continued to decline vaccination were asked to provide additional
information as to why they still preferred not to receive the vaccination. Based on those
who returned the survey, eight additional patients stated that would have received the
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vaccination if it was not for the timing of their scheduled Covid19 vaccinations which
were given priority due to the current pandemic. If, all eight of those patients would have
indeed received the pneumococcal vaccination the percentage would have increased to
84%, which would have increased the 10% improvement rate to 15%.
Evaluation of Theoretical Framework
The theoretical framework applied to this project was the P3 model. This
framework was a good fit for this project and provided a good blueprint for the basis of
the project because the project was able to follow the practice level, provider level, and
patient level components discussed in the framework that is seen in Figure 1 displayed in
Chapter 1. At the practice level, correct utilization of standing orders was addressed in
the staff education. At the provider level, the providers were educated regarding vaccine
hesitancy due to lack of education and correct utilization of the EHR prompts. Finally, at
the patient level, a survey was given to determine reasons why the patient may be the
reason for not vaccinating, such as fear of needles, unknown vaccine schedule or fear of
costs.
Evaluation of Logic Model
In Chapter 1 (Figure 2), a logic model was provided to show the short-term,
intermediate, and long-term outcomes of implementing provider and staff education on
ways to increase PPSV23 vaccination rates. The short-term goal of improvement of
clinical vaccination rates was met with this project. The project did not evaluate
improved clinician education regarding vaccination- although, while providers did
verbalize this to be true at the project conclusion, there was no official evaluation
method. The use of Show Me Vax (Missouri IIS) and EHR reminders were utilized
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throughout the project. Finally, there was also improvement of clinic vaccination rates.
The intermediate-goals and long-term goals will need further evaluation to assess on
future projects.
Limitations
This study was not without bias and limiting factors. The comparative/historical
data was pulled from April-May 2020. This was right in the middle of the Covid19
pandemic which could have skewed the total number of patient visits or the visit types
and this information was not pulled for confidentiality and HIPAA reasons.
The time allotted for data collection could also be considered a limiting factor.
After staff education data was only obtained for an eight-week period of time. A longer
allotment period would have assessed sustainability for intervention.
The study lacked clinic diversity as it was only performed using one clinic and the
staff employed within that clinic. This was due to social distancing guidelines and
attempting to limit staffing based on the Covid19 pandemic. This makes the study
potentially lack generalizability since there was no additional clinics studied.
Finally, the study lacked a diverse patient population to determine if there was
any vaccination bias based on rates or ethnicity. This data was pulled but there were
really only a few patients who identified as another race or ethnicity. There was lack of
data to determine if there is a difference across race and/or ethnic groups.
Implications for Future Projects
Limitations stated above should be addressed for future studies. Future studies
should be completed with larger sample sizes, additional clinics and larger geographical
areas, and obtain a more diverse patient population. Looking at reasons for vaccination
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refusals and coming up with ways to decrease reasons identified would also be areas for
additional project expansion.

Implications for Practice
Vaccinations are some of the best ways to prevent diseases and illnesses. The
incidence, prevalence, morbidity and mortality caused by vaccine-preventable diseases
have all been decreased by their use. There are many different vaccine-preventable
diseases however, and due to the significance regarding vaccination against
pneumococcal disease, there needs to be improvement in vaccination rates against this
disease. The State of Missouri, where this project was performed, has low PPSV23 rates,
and there is need for improvement. These low rates are proven to be both a state and a
healthcare issue, and the need for a health impact assessment may be beneficial for future
practice. In the State of Missouri, the pneumococcal vaccination rate is at 74.4%, which
was decreased from 77.7% in 2017 (CDC, 2019d). This gives Missouri plenty of room
for improvement. There needs to more effective programs to ensure there is an increase
in adult vaccination rates. This is where practice change is necessary.
The impacts of the PPSV23 are well documented. Getting vaccinated can protect
the individual receiving the vaccination. If the majority of a community gets vaccinated,
that community can develop what is called herd immunity, which decreases the
likelihood that the community will get the disease. This would be a decrease chance of an
outbreak because it is harder for the disease to spread. To improve pneumococcal
vaccination rates, it is necessary to identify barriers to increased uptake among the adult
population and to modify these where possible. This will help determine why
vaccination rates are low.
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Health impact assessments and quality improvement projects for future practice
can keep cost, access, education, and surveillance in mind. Providers need to understand
and educate regarding the importance of vaccination. This will help to decrease disease
and ultimately aid in disease eradication in the future.

Implications for Health Policy
There are often bills introduced to the House and Senate that relate back to
vaccinations. For example, there is currently a bill that was introduced to the House on
November 13, 2019, this was called "Protecting Seniors Though Immunization Act of
2019." This bill is to amend the Social Security Act to specify that "certain deductible,
coinsurance, initial coverage limit, and cost-sharing requirements that apply under the
Medicare prescription drug benefit shall not apply to vaccines that are recommended by
the Advisory Committee on Immunization Practices of the Centers for Disease Control
and Prevention” (GovTrack, 2021). This includes the PPSV23 vaccination. These bills
are necessary to help control vaccination access, pricing and ultimately improve
vaccination rates.
Implications for Education
A strong recommendation by a health care provider is the key reason that patients
choose to vaccinate. Studies show that patients who receive a provider recommendation
are 4-5 times more likely to receive a vaccination (CDC, 2019b). It is important for
providers to be educated on how important their recommendation is for patients to hear.
That way they can use a presumptive approach that assumes that the patient will
vaccinate if being offered.
This recommendation will be enough for most patients; - however, there will be
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some patients that will require more education and information prior to receiving the
vaccine. So, all healthcare members need education regarding vaccination schedules,
side effects, and efficacies. Additionally, they need to be able to be available to provide
patient with the needed resources for discussion of the benefits and risks of vaccination.

Conclusion
The aim of this scholarly project was to increase PPSV23 vaccination rates in
adults age 65 years of age and older in a midwestern primary care clinic after provider
and staff education were performed. Comparison of vaccination rates from April 1-May
31, 2020, to the same days in 2021 showed a 10% vaccination rate increase after the
intervention consisting of patient awareness of vaccination status, assessment of
vaccination status at the time of appointment, use of standing orders, provider
recommendation and use of EHR reminders.
The outcome of the study enhanced the awareness of the PPSV23 vaccination to
the providers and staff at the clinic in which the intervention was implemented. Even
though the study’s results are optimistic regarding the increase of PPSV23 vaccination
rates, recommendations for further research were addressed. In order to achieve an
PPSV23 vaccination rate of at least 90%, providers must continue to educate patients on
the cancer-preventing benefits the PPSV23 vaccination and make strong vaccination
recommendations to ultimately decrease pneumococcal-related illness.
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Appendix C

Pneumococcal Vaccination Survey:
We noticed today that you did not receive the pneumococcal vaccination.
This survey is attempting to gather information on reasons why. This is for
research purposes only and results will not be able to be placed back to you
nor will they affect the treatment you receive at our office.
Please check one or more of the boxes below:
 Lack of provider recommendation/ was not discussed or aware
 Lack of ability to pay or fear of cost
 Religious Reason
 Personal Belief
 Safety Concerns (regarding side effects)
 Fear (of needles)
 Desire for additional information
 Wanting to get the Covid vaccination and have to wait based on
timing
 Prefer not to disclose my reasoning
 Other, please describe______________________________________
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